CLINICAL_TRIALS trial_result · 2020-01-27

Clinical Trial Update: Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

Phase 2 clinical trial update on rasagiline in subjects with Amyotrophic Lateral Sclerosis (ALS) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Richard Barohn, MD | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: COMPLETED | Results posted: 2020-01-27